Format

Send to

Choose Destination
Gastroenterol Hepatol. 2020 Mar;43(3):169-177. doi: 10.1016/j.gastrohep.2019.11.005. Epub 2020 Feb 21.

Prophylaxis and treatment in liver transplantation. VII Consensus Document of the Spanish Society of Liver Transplantation.

[Article in English, Spanish]

Author information

1
Sociedad Española de Trasplante Hepático, Unidad de Hepatología y Trasplante Hepático, Hospital 12 de Octubre, Madrid, España.
2
Sociedad Española de Trasplante Hepático, Unidad de Trasplante Hepático, Hospital Virgen del Rocío, Sevilla, España.
3
Unidad de Trasplante Hepático, Hospital Clínic, IDIBAPS, CIBERehd, Univ. Barcelona, Barcelona, España. Electronic address: jcolme@clinic.cat.
4
H.U. Río Hortega.
5
H.U. de Bellvitge.
6
H.U. Reina Sofía.
7
H.U. Vall d'Hebrón.
8
H.U. Clinic i Provincial.
9
H.U. Puerta de Hierro Majadahonda.
10
H.U. Marqués de Valdecilla.
11
H.U. de Cruces.
12
H.U. Ramón y Cajal.
13
H.U. Central de Asturias.
14
Clínica Universitaria de Navarra.
15
H.U. La Paz.
16
H.U. Infanta Cristina.
17
H.U. Virgen de la Nieves.
18
H. Clínico U. de Santiago.
19
H.U. Juan Canalejo.
20
H.U. Nuestra Sra. de la Candelaria.
21
H. Gral. U. de Alicante.
22
H.U. Virgen de la Arrixaca.
23
H.U. La Fe.
24
H. Gral. U. Gregorio Marañón.
25
H. Clínico U. Lozano Blesa.

Abstract

Whilst prophylaxis of hepatitis B is universally accepted after liver transplantation (LT), national recommendations for the prophylaxis and treatment of hepatitis B virus (HBV) infection after LT are lacking in Spain. The aim of the VII consensus meeting organised by the Spanish Society of Liver Transplantation (SETH) was to set recommendations on the prophylaxis and treatment of hepatitis B after LT. The scientific evidence and strength of recommendations was evaluated by using the "Grading of Recommendations Assessment, Development and Evaluation" (GRADE) system. This document describes the recommendations and their level of evidence for: the definition and risk factors for hepatitis B recurrence after LT, monitoring and prophylaxis of hepatitis B recurrence at different periods after LT, treatment of hepatitis B before and after LT, and the prophylaxis of HBV infection by the recipients of LT with hepatitis B core antigen positive donors.

KEYWORDS:

Análogos nucleósidos; Core positive grafts; Donante anticore; Donor-derived infection; Immunoglobulin; Infección adquirida; Inmunoglobulina específica; Nucleotides; Vaccination; Vacuna

Supplemental Content

Full text links

Icon for Ediciones Doyma, S.L.
Loading ...
Support Center